| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.21 | 7e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |